Multispecific binding constructs against checkpoint molecules and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11046769
APP PUB NO 20200181266A1
SERIAL NO

16682756

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to compositions and methods for inhibiting tumor evasion by reducing immune checkpoint suppression. In some embodiments, provided herein are compositions that block the interaction between PD-1 and its ligand (e.g., PD-1 and/or PD-L2) while promoting the interaction of the cells on which PD-1 and its ligand are expressed. Also provided are methods of using such compositions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
COMPASS THERAPEUTICS LLC245 FIRST STREET 3RD FLOOR CAMBRIDGE MA 02142

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Albu, Diana I Windham, US 3 0
Bakhru, Pearl Ashland, US 3 0
Eskiocak, Ugur Somerville, US 25 78
Gong, Bing Brighton, US 41 116
Leung, Cheuk Lun Quincy, US 16 71
Oliphant, Amanda Frank Boston, US 5 5
Rennard, Rachel Stoneham, US 5 0
Wolf, Benjamin Jacob Seattle, US 7 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 29, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 29, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00